CC BY-NC-ND 4.0 · Laryngorhinootologie 2019; 98(S 02): S124
DOI: 10.1055/s-0039-1686336
Abstracts
Otology

Audiological phenotypic characterization of Usher-syndrome

D Back
1   HNO Universitätsklinik Würzburg, Würzburg
,
D Ehrmann-Müller
1   HNO Universitätsklinik Würzburg, Würzburg
,
M Hofrichter
2   Institut für Humangenetik der Universität Würzburg, Würzburg
,
J Schröder
2   Institut für Humangenetik der Universität Würzburg, Würzburg
,
T Haaf
2   Institut für Humangenetik der Universität Würzburg, Würzburg
,
R Hagen
1   HNO Universitätsklinik Würzburg, Würzburg
,
W Shehata-Dieler
1   HNO Universitätsklinik Würzburg, Würzburg
› Author Affiliations
 

Introduction:

Usher-syndrome causes about 50% of the combined hearing-/visual impairments. Depending on the type of mutation the syndrome can lead to a mild hearing impairment up to deafness with blindness. The autosomal-recessive disease is associated with damage of the synapses and stereocilia in the inner ear causing a sensorineural-hearing loss as well as a retinopathia pigmentosa resulting from lesions of the photoreceptors.

Methods:

Retrospective analysis of data of patients who were examined at the Comprehensive Hearing Center since 2011. Clinical audiological data as well as genetic investigations were collected. In some patients ophthalmological data were also available.

Results:

Since 2011 Usher-syndrome was detected in four children and one women. Different types of Usher-syndrome showed various severities of hearing loss, all were treated by conventional hearing aids or cochlea implants.

Conclusions:

With a prevalence of 3 – 6/100.000 Usher-syndrome is a pertinent cause of combined hearing-/visual impairment. Because of the fateful course of vision loss, the hearing impairment is an important feature for the detection of Usher-syndrome. Genetic examination offers an early diagnosis and accordingly the chance for coping with the disease. The hearing impairment often remains stable and can be successfully treated with hearing devices. However, the treatment of the retinopathia pigmentosa is still under research.



Publication History

Publication Date:
23 April 2019 (online)

© 2019. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Stuttgart · New York